<p>Enovis Co. (NYSE:ENOV - 获取免费报告) 的股价在周四的午盘交易中创下 52 周新低，此前 Needham &amp; Company LLC 将其目标价从 65.00 美元下调至 64.00 美元。Needham &amp; Company LLC 目前对该股票维持买入评级。Enovis 的股价最低曾达到 38.17 美元，最后交易价为 38.25 美元，成交量为 725459 股。该股票此前收盘价为 40.00 美元。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者和对冲基金最近买入和卖出了 ENOV 的股票。Raymond James &amp; Associates 在第三季度将其在 Enovis 的持股增加了 1076.7%。Raymond James &amp; Associates 目前拥有 56,692 股该公司的股票，价值 2,441,000 美元，此前在该期间购买了 51,874 股。路易斯安那州员工退休系统在第三季度将其在 Enovis 的股份增加了 9.9%。路易斯安那州员工退休系统目前拥有 15,500 股该公司的股票，价值 667,000 美元，此前在上个季度购买了 1,400 股。DekaBank Deutsche Girozentrale 在第三季度新建了一个价值约 55,000 美元的 Enovis 头寸。阿拉斯加州收入部在第三季度将其在 Enovis 的股份增加了 20.8%。阿拉斯加州收入部目前拥有 6,482 股该公司的股票，价值 279,000 美元，此前在上个季度购买了 1,115 股。最后，US Bancorp DE 在第三季度将其在 Enovis 的持股增加了 29.1%。US Bancorp DE 目前拥有 17,962 股该公司的股票，价值 773,000 美元，此前在该期间购买了 4,050 股。对冲基金和其他机构投资者持有该公司 98.45% 的股票。</p>
<h2>Enovis 价格表现</h2>
<p>该公司的流动比率为 2.27，速动比率为 1.12，债务与股本比率为 0.40。该公司的市值为 21.7 亿美元，市盈率为-17.42，贝塔值为 1.94。该公司的 50 日移动平均线为 44.90 美元，200 日移动平均线为 44.34 美元。</p>
<p>Enovis (NYSE:ENOV - 获取免费报告) 最近在 2 月 26 日星期三发布了季度财报。该公司报告季度每股收益为 0.98 美元，超出市场普遍预期的 0.92 美元，超出幅度为 0.06 美元。该公司季度收入为 5.6098 亿美元，而分析师预期为 5.5514 亿美元。Enovis 的净利润率为-5.95%，股本回报率为 4.39%。整体来看，分析师预测 Enovis Co.在当前年度将发布 2.79 美元的每股收益。</p>
<h2>Enovis 公司简介</h2>
<p>(获取免费报告)</p>
<p>Enovis Corporation 是一家医疗技术公司，专注于开发临床差异化的解决方案，业务遍及全球。它还制造和分销用于重建手术、康复、疼痛管理和物理治疗的医疗设备。该公司通过预防与恢复和重建两个部门运营。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比 Enovis 更好</li>
<li>卖空：如何做空一只股票</li>
<li>波动性回归：3 只股票可以缓冲标准普尔 500 的波动</li>
<li>股息捕捉策略：你需要知道的事项</li>
<li>可能推动 NVIDIA 股票上涨 30% 的两个催化剂</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>通用汽车股票回购是否使股票对投资者可买？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Enovis 吗？</h2>
<p>在你考虑 Enovis 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Enovis 并不在名单上。</p>
<p>虽然 Enovis 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ENOV

<p>Enovis (NYSE:ENOV) 达到新的 52 周低点 38.17 美元，此前 Needham & Company 将其目标价从 65.00 美元下调至 64.00 美元，但维持买入评级。该股收盘价为 38.25 美元，交易量为 725,459 股。机构投资者持有 98.45% 的股份，其中 Raymond James & Associates 等的持股显著增加。Enovis 报告上个季度每股收益为 0.98 美元，超出预期，收入为 5.6098 亿美元。分析师预测当前年度每股收益为 2.79 美元</p>

<p>Enovis Co. (NYSE:ENOV - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday after Needham &amp; Company LLC lowered their price target on the stock from $65.00 to $64.00. Needham &amp; Company LLC currently has a buy rating on the stock. Enovis traded as low as $38.17 and last traded at $38.25, with a volume of 725459 shares. The stock had previously closed at $40.00.</p>
<div class="lb-trans"><p>Enovis Co. (NYSE:ENOV - 获取免费报告) 的股价在周四的午盘交易中创下 52 周新低，此前 Needham &amp; Company LLC 将其目标价从 65.00 美元下调至 64.00 美元。Needham &amp; Company LLC 目前对该股票维持买入评级。Enovis 的股价最低曾达到 38.17 美元，最后交易价为 38.25 美元，成交量为 725459 股。该股票此前收盘价为 40.00 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of ENOV. Raymond James &amp; Associates raised its holdings in shares of Enovis by 1,076.7% during the third quarter. Raymond James &amp; Associates now owns 56,692 shares of the company's stock worth $2,441,000 after purchasing an additional 51,874 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of Enovis by 9.9% in the third quarter. Louisiana State Employees Retirement System now owns 15,500 shares of the company's stock worth $667,000 after purchasing an additional 1,400 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in Enovis during the 3rd quarter valued at about $55,000. State of Alaska Department of Revenue boosted its stake in Enovis by 20.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 6,482 shares of the company's stock valued at $279,000 after purchasing an additional 1,115 shares in the last quarter. Finally, US Bancorp DE grew its holdings in Enovis by 29.1% during the third quarter. US Bancorp DE now owns 17,962 shares of the company's stock worth $773,000 after acquiring an additional 4,050 shares during the period. Hedge funds and other institutional investors own 98.45% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近买入和卖出了 ENOV 的股票。Raymond James &amp; Associates 在第三季度将其在 Enovis 的持股增加了 1076.7%。Raymond James &amp; Associates 目前拥有 56,692 股该公司的股票，价值 2,441,000 美元，此前在该期间购买了 51,874 股。路易斯安那州员工退休系统在第三季度将其在 Enovis 的股份增加了 9.9%。路易斯安那州员工退休系统目前拥有 15,500 股该公司的股票，价值 667,000 美元，此前在上个季度购买了 1,400 股。DekaBank Deutsche Girozentrale 在第三季度新建了一个价值约 55,000 美元的 Enovis 头寸。阿拉斯加州收入部在第三季度将其在 Enovis 的股份增加了 20.8%。阿拉斯加州收入部目前拥有 6,482 股该公司的股票，价值 279,000 美元，此前在上个季度购买了 1,115 股。最后，US Bancorp DE 在第三季度将其在 Enovis 的持股增加了 29.1%。US Bancorp DE 目前拥有 17,962 股该公司的股票，价值 773,000 美元，此前在该期间购买了 4,050 股。对冲基金和其他机构投资者持有该公司 98.45% 的股票。</p>
</div><h2>Enovis Price Performance</h2>
<div class="lb-trans"><h2>Enovis 价格表现</h2>
</div><p>The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $2.17 billion, a P/E ratio of -17.42 and a beta of 1.94. The business's fifty day moving average is $44.90 and its 200 day moving average is $44.34.</p>
<div class="lb-trans"><p>该公司的流动比率为 2.27，速动比率为 1.12，债务与股本比率为 0.40。该公司的市值为 21.7 亿美元，市盈率为-17.42，贝塔值为 1.94。该公司的 50 日移动平均线为 44.90 美元，200 日移动平均线为 44.34 美元。</p>
</div><p>Enovis (NYSE:ENOV - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.06. The firm had revenue of $560.98 million for the quarter, compared to analysts' expectations of $555.14 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. As a group, analysts forecast that Enovis Co. will post 2.79 EPS for the current year.</p>
<div class="lb-trans"><p>Enovis (NYSE:ENOV - 获取免费报告) 最近在 2 月 26 日星期三发布了季度财报。该公司报告季度每股收益为 0.98 美元，超出市场普遍预期的 0.92 美元，超出幅度为 0.06 美元。该公司季度收入为 5.6098 亿美元，而分析师预期为 5.5514 亿美元。Enovis 的净利润率为-5.95%，股本回报率为 4.39%。整体来看，分析师预测 Enovis Co.在当前年度将发布 2.79 美元的每股收益。</p>
</div><h2>Enovis Company Profile</h2>
<div class="lb-trans"><h2>Enovis 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.</p>
<div class="lb-trans"><p>Enovis Corporation 是一家医疗技术公司，专注于开发临床差异化的解决方案，业务遍及全球。它还制造和分销用于重建手术、康复、疼痛管理和物理治疗的医疗设备。该公司通过预防与恢复和重建两个部门运营。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Enovis</li>
<li>Short Selling: How to Short a Stock</li>
<li>Volatility Is Back: 3 Stocks To Cushion the S&amp;P 500's Swings</li>
<li>Dividend Capture Strategy: What You Need to Know</li>
<li>2 Catalysts That Could Push NVIDIA Stock Up 30% This Year</li>
<li>What is a buyback in stocks? A comprehensive guide for investors</li>
<li>Do GM Stock Buybacks Make the Stock Buyable For Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Enovis 更好</li>
<li>卖空：如何做空一只股票</li>
<li>波动性回归：3 只股票可以缓冲标准普尔 500 的波动</li>
<li>股息捕捉策略：你需要知道的事项</li>
<li>可能推动 NVIDIA 股票上涨 30% 的两个催化剂</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>通用汽车股票回购是否使股票对投资者可买？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Enovis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Enovis 吗？</h2>
</div><p>Before you consider Enovis, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Enovis 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Enovis 并不在名单上。</p>
</div><p>While Enovis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Enovis 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Enovis（纽约证券交易所代码：ENOV）因分析师下调评级创下一年新低